🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Increasing Lung Cancer Screening Uptake Among Emergency Department Patients

RecruitingNAAges 50 Years - 80 YearsAllUniversity of Rochester
NCT07287085 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The objective of the proposed clinical trial is to determine if we can increase LCS among ED patients using a combination of facilitated referral to an LCS program plus text message reminders to get screened. Step 1 of the approach is to identify participants that are eligible for LCS. Step 2 is to randomize eligible study participants between two study arms: (1) basic referral for LCS (i.e. verbal referral with written materials), and (2) facilitated referral for LCS (i.e. submission of a requisition to LCS program by staff) plus a subsequent series of text messages aimed at generating intention and motivation to get screened. The investigators' preliminary work showed this approach was feasible in the ED setting. The proposed study will build on this preliminary work with the goal of having a significant positive impact on LCS uptake. A total of 300 individuals eligible for LCS will

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 50 - 80 * ≥ 20 pack-year smoking history * current smoker or quit within 15 years * English speaking * Current patient in URMC involved Emergency Department Exclusion Criteria: * Non-English * Inability to provide consent (e.g. high clinical acuity, cognitive deficit) * Lack of text-capable mobile phone and/or inability to use text function * Not being a patient in URMC involved Emergency Department There are no restrictions for gender, racial and ethnic origins.
💊

What it tests

  • Facilitated referral and text messaging
  • Basic Referral (enhanced control arm)
📍

Where

1 site
University of Rochester
Rochester, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy